Regenerative MedicineResearch PaperPaywall

Lab-Grown Menstrual Cycle Reveals How the Uterus Regenerates Without Scarring

Scientists built the first in vitro menstrual cycle using organoids, uncovering WNT7A as a key driver of scarless endometrial regeneration.

Friday, May 1, 2026 0 views
Published in Cell Stem Cell
A researcher examining a cluster of translucent organoids in a petri dish under a laboratory microscope, with pink-stained tissue cross-sections visible on a light box in the background

Summary

Researchers at the Friedrich Miescher Institute created a lab-based model of the human menstrual cycle using endometrial organoids — tiny tissue structures grown from human cells. This in vitro menstrual cycle (IVMC) closely mimics what happens inside the uterus during menstruation and regeneration. By comparing the organoid model to real tissue samples, the team identified a unique gene signature active during menstruation, centered on a signaling molecule called WNT7A. When WNT7A was removed, organoids failed to survive long-term, suggesting it plays a critical role in tissue renewal. The study also found that regenerating tissue acts as a communication hub, coordinating with blood vessels to rebuild the uterine lining. This model could transform research into conditions like endometriosis and infertility.

Detailed Summary

The human endometrium is one of the few tissues in the body capable of cyclical shedding and complete, scarless regeneration — a process that repeats roughly 400 times over a woman's reproductive life. Despite its importance to reproductive health, the cellular mechanisms driving this regeneration have remained poorly understood, largely because the critical perimenstrual window is difficult to study in living patients.

Researchers at the Friedrich Miescher Institute for Biomedical Research in Basel developed an in vitro menstrual cycle (IVMC) protocol using human endometrial organoids. These are three-dimensional tissue models grown from human endometrial cells that can be hormonally cycled to mimic the phases of the menstrual cycle in a dish. The team validated their model by comparing it against real human tissue samples using histology, transcriptomic profiling, and multiplex secreted-protein analysis.

A key discovery was the identification of WNT7A as a defining molecular marker of the luminal epithelium during menstruation. WNT7A is part of the WNT signaling pathway, which is broadly involved in tissue development and stem cell maintenance. When WNT7A was experimentally silenced, organoids lost the ability to survive over the long term, confirming its functional necessity in endometrial renewal.

The study also revealed that the regeneration-associated luminal epithelium acts as a signaling hub, communicating with the vasculature to coordinate tissue rebuilding. This vascular crosstalk may be essential for the rapid, scar-free repair that distinguishes the endometrium from most other tissues.

These findings open new research avenues for conditions like endometriosis, abnormal uterine bleeding, and implantation failure — all of which involve disrupted endometrial regeneration. The IVMC platform provides a reproducible, ethically accessible model to study these diseases and test potential therapies. Caveats include the absence of stromal, immune, and vascular cell types in the organoid system.

Key Findings

  • First in vitro menstrual cycle model using human endometrial organoids validated against real tissue samples.
  • WNT7A expression marks a distinct transcriptomic state in luminal epithelium during menstruation.
  • Loss of WNT7A compromises long-term organoid survival, confirming its role in endometrial regeneration.
  • Regenerating luminal epithelium acts as a signaling hub coordinating with vasculature during tissue repair.
  • Model enables study of the previously inaccessible perimenstrual window in reproductive health and disease.

Methodology

Human endometrial organoids were subjected to a hormone-driven in vitro menstrual cycle (IVMC) protocol. Validation was performed by benchmarking organoid behavior against in vivo human tissue samples using histology, transcriptomics, and multiplex secreted-protein analysis. WNT7A function was assessed through loss-of-function experiments in the organoid system.

Study Limitations

The summary is based on the abstract only, as the full paper is not open access. The organoid model captures epithelial dynamics but likely lacks the stromal, immune, and vascular cell complexity of the in vivo endometrium. Functional conclusions about WNT7A are drawn from organoid experiments and may not fully translate to whole-tissue physiology.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.